Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-11-20
1992-09-01
Chan, Y. Christina
Drug, bio-affecting and body treating compositions
Lymphokine
424 89, 530324, 530325, 530326, 530327, 530328, 530345, 530350, 530403, 530806, 530809, 530826, A61K 3900, A61K 3929, C07K 700, C07K 1500
Patent
active
051437260
ABSTRACT:
Polypeptides corresponding in amino acid residue sequence to T cell stimulating regions of the HBV nucleocapsid protein are disclosed. A method of enhancing the immunogenicity of a polypeptide immunogen comprising operatively linking the polypeptide through an amino acid residue side chain to core protein particles is also disclosed.
REFERENCES:
patent: 4818527 (1989-04-01), Thornton et al.
patent: 4882145 (1989-11-01), Thornton et al.
Clark et al., Nature, 330:381-384 (1987).
Rudinger, Peptide Hormones, Parsons (Ed.) U. Park Press, Baltimore, pp. 1-7 (1976).
Talmadge et al., 13th International Congress of Chemotherapy, Proceedings (Spitzy et al. Ed.) pp. 203/19-203/35 (1983).
McLachlan Alan
Milich David R.
Moriarty Ann M.
Thornton George B.
Bingham Douglas A.
Chan Y. Christina
The Scripps Research Institute
LandOfFree
T cell epitopes of the hepatitis B virus nucleocapsid protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with T cell epitopes of the hepatitis B virus nucleocapsid protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T cell epitopes of the hepatitis B virus nucleocapsid protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-766430